
    
      Upon determination of eligibility, patients will be receive:

        -  Rituxan + CHOP or CVP + Ibritumomab Tiuxetan

      Patients who are considered medical candidates for doxorubicin should receive CHOP
      chemotherapy (Cyclophosphamide, doxorubicin, vincristine and prednisone). Patients who are
      not considered medical candidates for doxorubicin should receive CVP chemotherapy
      (Cyclophosphamide, Vincristine, and prednisone)
    
  